Testing MRG004A for advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new drug called MRG004A (plus best supportive care) against a placebo (plus best supportive care) for people with advanced pancreatic cancer who have already tried chemotherapy. The goal is to see if MRG004A can help shrink or slow the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with advanced pancreatic cancer (locally advanced or spread to other parts of the body).
- You have already tried at least one prior chemotherapy (including gemcitabine and/or fluorouracil) that didn't work or stopped working.
- You have at least one tumor that can be measured on a scan.
- You are generally able to get out of bed and take care of yourself for at least half the day.
- You are not pregnant and agree to use effective birth control during treatment and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests personalized therapies for people with advanced pancreatic cancer that has spread or cannot be removed. It aims to find the best treatment based on your tumor's unique features.
This trial tests whether combining two experimental drugs (GFH375 with GFS202A or GFH276) works better than one drug alone for people with advanced pancreatic cancer that has a specific genetic change called KRAS G12D. It may offer a new option for those who have already tried other treatments.
This trial tests a new cell therapy (BGT007H) for people with advanced pancreatic cancer that has not responded to earlier treatments. The goal is to see if it is safe and can help shrink or control the cancer.
This trial tests a new drug called MRG003 combined with gemcitabine for people with advanced pancreatic cancer that has stopped responding to or cannot tolerate initial treatment. It aims to see if the combination can shrink tumors or slow the disease.
This trial tests a new drug, MRG006A, for people with advanced solid tumors, especially liver cancer. It aims to see if the drug is safe and effective by targeting a protein called GPC3 found on some cancer cells.
This trial tests a new drug called MRG007 combined with other treatments for people with advanced colorectal cancer that cannot be removed by surgery or has spread. It aims to see if the combination is safe and effective.
Hear when a new Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.